Browsing by AJOU Author : 강석윤

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 34 to 68 of 68

Pub YearTitleAuthor(s)
2013Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression.강석윤, 김장희, 박태준, 임현이, 정용식
2013Granulocytic sarcoma in breast after bone marrow transplantation.강두경, 강석윤, 김구상, 김태희, 임현이, 정성현, 정용식
2012Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection강석윤, 김영배, 김장희, 박준성, 신승수, 안미선, 이현우, 정성현, 조용관, 최진혁, 한상욱, 한재호
2016High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy강석윤, 김장희, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한재호
2021Implications of tamoxifen resistance in palbociclib efficacy for patients with hormone receptor-positive, her2-negative metastatic breast cancer: Subgroup analyses of kcsg-br15-10 (youngpearl)강석윤
2015Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?강석윤, 박준성, 안미선, 이순영, 이현우, 정성현, 최용원, 최진혁
2007Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy.강석윤, 강승희, 김장희, 김효철, 박준성, 신승수, 오영택, 이광재, 이현우, 전미선, 최진혁, 한재호
2012Magnetic resonance imaging patterns of tumor regression after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity강두경, 강석윤, 김구상, 김태희, 임현이, 정용식
2015Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer.강석윤
2017Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients강석윤
2013Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905).강석윤
2015Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation.강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁
2009Outcome of Locally Advanced Esophageal Cancer Treated with Concurrent Chemo-radiotherapy강석윤, 강승희, 오영택, 전미선, 최진혁
2014Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-cell lymphoma patients treated with rituximab-CHOP.강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁
2019Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY)강석윤
2013Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02.강석윤
2018Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in gastric cancer patients who underwent palliative chemotherapy강석윤, 안미선, 이현우, 최용원, 최진혁
2017Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis강석윤, 안영실, 윤준기, 이수진, 임현이
2016Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study강석윤
2015Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02).강석윤
2012Risk Reducing Surgery in Carriers with Double Heterozygosity for BRCA1 and BRCA2 Mutations강두경, 강석윤, 김구상, 김태희, 박명철, 임현이, 장석준, 전미선, 정용식, 홍우성
2019S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial강석윤
2018Should combination chemotherapy be used in all advanced gastric cancer patients?강석윤, 안미선, 이현우, 최용원, 최진혁
2007Small cell carcinoma of the gall bladder: Two case reports강석윤, 김효철, 이현우, 임현이, 최진혁
2018Strong immunoexpression of dickkopf-1 is associated with response to bortezomib in multiple myeloma강석윤, 김장희, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁, 한재호
2013Thalidomide Associated Gynecomastia in a Patient with Malignant Histiocytosis: A Case Report강두경, 강석윤, 김구상, 김지영, 김태희, 박준성, 신현주, 임현이, 정용식
2019The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study강석윤
2007The Outcome of Postoperative Radiation Therapy for Patients with Stage II Pancreatic Cancer (T3 or N1 Disease)강석윤, 강승희, 김명욱, 김욱환, 오영택, 전미선
2009The Results of Radiotherapy in Locally Advanced, Unresectable Pancreatic Cancer강석윤, 강승희, 오영택, 전미선
2019The role of surgical resection before palliative chemotherapy in advanced gastric cancer강석윤, 박준성, 손상용, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한상욱, 허훈
2018The role of third-line chemotherapy in recurrent or metastatic gastric cancer: A cohort study with propensity score matching analysis강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁
2013Usefulness of 18F-fluoride PET/CT in Breast Cancer Patients with Osteosclerotic Bone Metastases강석윤, 김구상, 안영실, 윤준기, 이수진
2014Utility of MRI and PET/CT after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity.강두경, 강석윤, 김구상, 김태희, 안영실, 임현이, 정용식
2016Value of volume-based metabolic parameters for predicting survival in breast cancer patients treated with neoadjuvant chemotherapy강두경, 강석윤, 김지영, 김태희, 안영실, 윤준기, 임현이, 정용식, 한세환
2017Young Age Is Associated with Increased Locoregional Recurrence in Node-Positive Breast Cancer with Luminal Subtypes강석윤, 임현이, 전미선, 정용식, 최진혁, 한세환
1 2

Browse